LIVE In-person at the Sunny Hotel or LIVE Interactive Streaming Recorded for On-Demand Viewing- Attendees Only!
| Course Co-Directors | |
|---|---|
| Barbara Coffey, M.D., MS | Luca Pani, M.D. |
| Course Planners | |
|---|---|
|
Giuliana Altare, DNP, APRN, PMHNP-BC Barbara Coffey, M.D., MS |
Kim Miele Luca Pani, M.D. |
| World-Renowned Faculty | |
|---|---|
|
Giuliana Altare, DNP, APRN, PMHNP-BC Barbara J. Coffey, M.D., MS Elizabeth A. Crocco, M.D. Ariadna Forray, M.D. Felicia Giuseppina Gallucci, M.D. Nassir Ghaemi, M.D., MPH Philip D. Harvey, Ph.D. Sogol Javaheri, M.D., MPH |
Alexander Kolevzon, M.D. Charles B. Nemeroff, M.D., Ph.D. Luca Pani, M.D. Gerard Sanacora, M.D., Ph.D. Alan F. Schatzberg, M.D. Azizi Seixas, Ph.D. Daniel R. Weinberger, M.D. Roger D. Weiss, M.D. |
-
Course Description
Psychopharmacology is undergoing one of its most significant transformations in decades. Advances in neuroscience, precision medicine, artificial intelligence, digital assessment, and novel therapeutics are changing how clinicians evaluate, monitor, and treat psychiatric illness. As the science evolves, clinicians need practical guidance on which innovations are ready for clinical use and what should change in practice now.
Living Legends in Psychopharmacology 2027: Precision Prescribing for Complex Patients - What Changes Monday Morning brings together internationally recognized pioneers and thought leaders to translate emerging science into practical strategies for psychiatrists, primary care physicians, psychiatric nurse practitioners, physician assistants, psychologists, pharmacists, and other mental health professionals caring for patients with complex psychiatric disorders.
This immersive two-day master class moves beyond a traditional medication update to examine how neuroscience, inflammation, neuroplasticity, biomarkers, artificial intelligence, digital phenotyping, and novel therapeutic mechanisms are reshaping psychiatric practice. Faculty will address treatment-resistant depression, schizophrenia and psychotic disorders, bipolar disorder, autism spectrum disorder, eating disorders, substance use disorders, sleep and circadian disturbances, and complex psychiatric presentations across the lifespan.
Participants will critically examine the latest evidence surrounding rapid-acting antidepressants, ketamine, psychedelic-assisted therapies, neuromodulation, contemporary antipsychotic treatment, digital assessment, and other emerging approaches. Special attention will be given to treatment selection, medication sequencing, switching and augmentation, safety monitoring, adverse-effect management, rational polypharmacy, and deprescribing.
The program will also address the distinct psychopharmacologic needs of children and adolescents, women during the reproductive years, and older adults. Faculty will explore how age, comorbidity, cognitive status, reproductive considerations, substance use, sleep disturbances, and medication burden influence treatment decisions.
Through evidence-based presentations, interactive polling, challenging cases, expert panels, and candid discussions of where the evidence remains uncertain, participants will see how leading clinicians approach difficult diagnoses and high-stakes prescribing decisions in real-world practice. Registrants will also have an opportunity to submit de-identified cases for consideration during the course’s interactive case discussions.
Every faculty member will be asked to answer one central question:
What should clinicians do differently on Monday morning?
Participants will leave with evidence-based strategies, practical prescribing pearls, and immediately applicable clinical insights to improve diagnostic accuracy, personalize treatment selection, enhance medication safety, and optimize outcomes for challenging patients. More than a traditional psychopharmacology update, Living Legends in Psychopharmacology 2027 offers a distinctive opportunity to learn not only what many of the field’s leading experts know, but how they think, decide, and prepare for what comes next.
Why Attend
- Strengthen treatment decisions for resistant depression, schizophrenia, bipolar disorder, and complex polypharmacy.
- Improve medication selection, sequencing, switching, augmentation, monitoring, and discontinuation.
- Evaluate emerging therapeutics, artificial intelligence, biomarkers, cognitive assessment, and digital phenotyping.
- Apply precision prescribing across the lifespan and in reproductive psychiatry.
- Compare expert reasoning through challenging cases and audience polling.
- Leave with practical strategies for situations in which evidence is incomplete, and no option is clearly superior.
New This Year: Submit a Clinical Case
Registrants may submit a challenging clinical case for possible faculty discussion. Cases must be de-identified before submission and must not contain Protected Health Information (PHI) or any direct or indirect information that could reasonably identify a patient. Submitters must comply with applicable federal and state privacy laws and their institutional policies. Submission does not guarantee selection; detailed instructions will follow once attendee is registered in the attendee confirmation email as to how to submit a clinical case.
-
Objectives
Course Highlights
- Legendary, field-defining faculty
- Current and emerging evidence-based treatments
- Innovations in the management of schizophrenia and bipolar disorder
- Advances in the treatment of bipolar depression and treatment-resistant depression
- Psychedelic-assisted therapy and ketamine: indications, mechanisms, and integration
- Next-generation neuromodulation: TMS, ECT, and beyond
- Psychopharmacologic strategies for anxiety syndromes, autism spectrum disorders, and sleep disturbances
- Comprehensive updates in PTSD treatment
- The evolving interface of psychiatry with neurology and primary care medicine
- Pharmacologic approaches to alcohol and substance use disorders
- Psychopharmacologic care across the reproductive lifespan in women’s mental health
- Age-sensitive psychopharmacology for children, adolescents, and older adults
- The ethical and clinical implications of Artificial Intelligence in psychiatry
Course Objectives
Upon completion of this activity, participants will be able to:
- Apply advances in neuroscience, inflammation, neuroplasticity, and biomarker research to evidence-based psychopharmacologic treatment selection.
- Evaluate the evidence, potential benefits, limitations, safety considerations, regulatory status, and appropriate clinical roles of rapid-acting antidepressant treatments, ketamine and esketamine, psychedelic-assisted therapies, neuromodulation, and other emerging interventions.
- Develop evidence-based treatment strategies for patients with treatment-resistant depression, schizophrenia and other psychotic disorders, bipolar disorder, autism spectrum disorder, eating disorders, substance use disorders, sleep disturbances, and complex psychiatric comorbidities.
- Apply evidence-based approaches to antipsychotic selection, medication sequencing, augmentation, switching, therapeutic monitoring, adverse-effect management, rational polypharmacy, and medication discontinuation.
- Apply precision-prescribing principles to psychiatric treatment across the lifespan, including children and adolescents, individuals during the reproductive years, and older adults.
- Evaluate the evidence supporting digital phenotyping, cognitive assessment, biomarkers, artificial intelligence, and other technology-enabled approaches to psychiatric evaluation, treatment selection, and outcome monitoring.
- Assess the clinical opportunities, limitations, ethical considerations, privacy concerns, and potential biases associated with artificial intelligence and digital technologies in psychiatric care.
- Differentiate bipolar and unipolar mood disorders using clinical features and available diagnostic evidence to improve diagnostic accuracy and guide treatment selection.
- Apply evidence-based pharmacologic, behavioral, and circadian strategies to address sleep disturbances in patients with psychiatric disorders.
- Integrate current evidence, patient characteristics and preferences, safety considerations, and clinical reasoning into individualized treatment decisions for patients with complex psychiatric illness.
- Legendary, field-defining faculty
-
Agenda
Friday, March 5, 2027
Breakthrough Treatments, Precision Prescribing, and Complex Mood Disorders
Time Presentation Faculty 7:00–8:00 a.m. Registration and Continental Breakfast — 8:00–8:15 a.m. Welcome and Overview Barbara J. Coffey, MD, MS 8:15–9:00 a.m. Paradise Lost: The Neurobiology of Child Abuse and Neglect Charles B. Nemeroff, MD, PhD 9:00–9:45 a.m. Treatment-Resistant Depression: Ketamine, Neuromodulation, Medication Sequencing, and What Comes Next Alan F. Schatzberg, MD 9:45–10:30 a.m. Trustworthy AI in Psychiatric Care: Ethics, Equity, Bias, and Responsible Clinical Adoption Azizi Seixas, PhD 10:30–11:00 a.m. Coffee Break — 11:00–11:45 a.m. From Genes to How the Brain Works Daniel R. Weinberger, MD 11:45 a.m.–12:30 p.m. Five Leaders. Decades of Discovery. One Candid Conversation About the Future of Psychiatric Treatment.
Living Legends Roundtable: What We Have Learned, What Has Changed, and What Comes Next in Psychopharmacology; Q&ACharles B. Nemeroff, MD, PhD; Alan F. Schatzberg, MD; Azizi Seixas, PhD; and Daniel R. Weinberger, MD; moderated by Barbara J. Coffey, MD, MS 12:30–1:45 p.m. Lunch — 1:45–2:30 p.m. Rapid-Acting Treatments and Biomarkers for Depression: What Is Ready for Clinical Practice? Gerard Sanacora, MD, PhD 2:30–3:15 p.m. Beyond Dopamine: Contemporary Schizophrenia Pharmacotherapy, Cognitive Outcomes, and Digital Assessment Philip D. Harvey, PhD 3:15–3:30 p.m. Coffee Break — 3:30–4:15 p.m. Expert Panel: Translating Novel Pharmacotherapies, Biomarkers, AI, and Digital Tools into Better Patient Care; Q&A Philip D. Harvey, PhD and Gerard Sanacora, MD, PhD; moderated by Barbara J. Coffey, MD, MS 4:15–5:00 p.m. Precision Psychiatry Case Lab: Depression, Psychosis, and Three Difficult Treatment Decisions Gerard Sanacora, MD, PhD; Philip D. Harvey, PhD; and Luca Pani, MD; moderated by Barbara J. Coffey, MD, MS 5:00–5:15 p.m. Friday Clinical Synthesis: Ten Practice-Changing Decisions for Monday Morning Barbara J. Coffey, MD, MS and Luca Pani, MD 5:15 p.m. Adjourn — Saturday, March 6, 2027
Precision Psychopharmacology Across Populations and the Lifespan
Time Presentation Faculty 7:00–7:45 a.m. Continental Breakfast — 7:45–8:00 a.m. Welcome and Overview Luca Pani, MD 8:00–8:45 a.m. Precision Psychopharmacology in Children and Adolescents: Treating the Patient, Not Just the Diagnosis Barbara J. Coffey, MD, MS 8:45–9:30 a.m. Autism Beyond Behavior: New Targets and Emerging Pharmacologic Treatments Alexander Kolevzon, MD 9:30–10:15 a.m. Eating Disorders Across the Lifespan: Psychopharmacology, Comorbidity, and Personalized Care Felicia Giuseppina Gallucci, MD 10:15–10:45 a.m. Coffee Break — 10:45–11:15 a.m. Perinatal Psychopharmacology: Balancing Maternal Mental Health and Reproductive Safety Ariadna Forray, MD 11:15 a.m.–12:00 p.m. Interactive Expert Panel: Treating Children, Adolescents, and Patients with Complex Comorbidities; Q&A Barbara J. Coffey, MD, MS; Ariadna Forray, MD; Felicia Giuseppina Gallucci, MD; Alexander Kolevzon, MD; and moderated by Luca Pani, MD 12:00–1:15 p.m. Lunch — 1:15–2:00 p.m. Healthy Brain Aging: Diagnosis, Safe Prescribing, and Medication Discontinuation in Older Adults Elizabeth A. Crocco, MD 2:00–2:45 p.m. Addiction Psychiatry 2027: New Medications and Integrated Treatment for Complex Comorbidity Roger Weiss, MD 2:45–3:00 p.m. Coffee Break — 3:00–3:45 p.m. Sleep as a Therapeutic Target: Pharmacologic and Circadian Strategies for Psychiatric Practice Sogol Javaheri, MD, MPH 3:45–4:30 p.m. Beyond the Bipolar–Unipolar Divide: Improving Diagnosis and Treatment Selection Nassir Ghaemi, MD, MPH 4:30–5:15 p.m. Mastering Complex Psychopharmacology: Sequencing, Monitoring, Medication Discontinuation, and Ten Practice-Changing Pearls for Monday Morning; Q&A Elizabeth A. Crocco, MD; Roger Weiss, MD; Sogol Javaheri, MD, MPH; Nassir Ghaemi, MD, MPH; and moderated by Luca Pani, MD -
Faculty
-
Accreditation
Living Legends in Psychopharmacology 2027: Precision Prescribing for Complex Patients - What Changes Monday Morning?
March 5, 2027 - March 6, 2027
LIVE In-person at the Sunny Hotel or LIVE Interactive Streaming Recorded for On-Demand Viewing- Attendees Only!
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and University of Miami, Department of Psychiatry and Behavioral Sciences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Amedco Joint Accreditation Provider Number: 4008163
Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this live activity for a maximum of 14.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 14.75 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 14.75 ANCC contact hours.
Psychologists
This course is co-sponsored by Amedco and University of Miami, Department of Psychiatry and Behavioral Sciences. Amedco is approved by the American Psychological Association to sponsor continuing education for psychologists. Amedco maintains responsibility for this program and content. Maximum of 14.75 hours.The following state boards accept courses from APA providers for Psychologists/Counselors: AK, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, MA, ME, MN, MO, NC, ND, NH, NE, NJ, NM, NV, OH, OK*, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
MA: Accepts APA for all classes of psychology license; does not accept APA for licensed counselors (LMHC, LMFT, etc.) except LEP.
MD: Does not accept Jointly Accredited content.
MI: Accepts courses from APA for Psychologists. No general CE requirement for Counselors.
OK: Accepts APA credit for live, in-person activities but not for ethics and/or online courses.
The following state boards accept courses from APA providers for MFTs: AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IN, KS, MD, ME, MO, NE, NC, NH, NJ, NM, NV, OH, OK*, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WDC, WI, WY
AL MFTs: Credits authorized by NBCC or any other state licensing agency will be accepted.
Social Workers
Application for social work continuing education credit has been submitted. Please contact Kim Miele at psychcme@med.miami.edu with any questions.
National Board of Certified Counselors
University of Miami Miller School of Medicine Department of Psychiatry and Behavioral Sciences has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7482. Programs that do not qualify for NBCC credit are clearly identified. University of Miami Miller School of Medicine Department of Psychiatry and Behavioral Sciences is solely responsible for all aspects of the programs.Inquiries
By phone at 941-539-0500, Monday–Friday, 9 a.m. to 4 p.m. (ET), or by email at psychcme@med.miami.edu.
Disclosure and Conflict of Interest Mitigation
Amedco LLC and the University of Miami, Department of Psychiatry and Behavioral Sciences, have assessed conflicts of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest have been mitigated.
Amedco LLCand University of Miami, Department of Psychiatry and Behavioral Sciences planners, content reviewers, and editorial staff disclose no relationships with ineligible entities. All the relevant financial relationships for these individuals have been mitigated.
ABMS/ACGME Competencies
All seminars are designed to meet the following American Board of Medical Specialties (ABMS)/ Accreditation Council for Graduate Medical Educational (ACGME) competencies:
- Patient Care and Procedural Skills
- Medical Knowledge
- Practice-based Learning and Improvement
- Interpersonal and Communication Skills
Target Audience
The winter seminars are a series of seminars for health professionals in psychiatry, psychology, pharmacy, neurology, medicine, surgery, geriatrics, pediatrics, nursing, social work, and counseling.
-
Registration
Seminar Format
Meets Friday, 8:15 a.m.–5:15 p.m., and Saturday, 8:00 a.m.–5:15 p.m.
Special Requests
If special arrangements are required for an individual with a disability to attend this conference, contact Kim Miele at psychcme@med.miami.edu at least 15 days prior to the conference.
Tuition
Living Legends – Registration Information
Early Bird Rates (Available Through December 18, 2027)
- Physicians, Nurse Practitioners, and Other Health Professionals: $995
- Residents, Fellows-in-Training, and Full-time Students: $840
Standard Rates (Effective December 19, 2027)
- All Registrants: $1,095
- Residents, Fellows-in-Training, and Full-time Students: $895
- Non-refundable Administrative Processing Fee: $20 (applies to all registrations)
Payment Method
- Registration must be completed by credit card (Visa, MasterCard, or American Express).
Refund Policy
Refunds, less an administrative fee of $100, will be issued for all cancellations received two weeks prior to the start of the course. Refund requests must be received by email. Please email psychcme@miami.edu. No refund will be issued should cancellation occur less than two weeks prior. “No shows” are subject to the full course fee, and no refunds will be issued once the conference has started.
Registration Information Link
To register, click the link below
Printed Syllabus
Price: $95.00
(Please note, all syllabus purchases are non-refundable and non-shippable and must be picked up on-site at the conference)
The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide. As an alternative to purchasing a conference syllabus, we provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.
Syllabus
Price: $95.00
You must order your printed syllabus in advance online when you register. The syllabus must be picked up onsite at the conference. Please note, we cannot ship the syllabus or refund your purchase.
E-Syllabus
We provide all attendees with free access to all slide presentations in digital PDF format before the conference. This environmentally friendly alternative helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Please include an email address you check frequently. We use your email address for critical information, including registration confirmation, evaluation, and your certificate.
-
Venue Information
Discover your perfect beachfront escape at The Sunny, an oceanfront boutique hotel in beautiful Sunny Isles Beach, Florida. Family-owned for three generations, The Sunny blends fresh, modern design with a cherished tradition of warm, personalized hospitality, creating a welcoming retreat where guests can relax, recharge, and experience the best of South Florida.
Spend your days lounging beside our newly renovated oceanfront pool while enjoying full-service food and cocktails, maintain your routine in our state-of-the-art fitness center and dedicated studios, or savor breakfast, lunch, dinner, and handcrafted cocktails at Julene, our signature restaurant.
Just steps from the hotel, the historic Newport Fishing Pier offers Miami Beach’s only over-the-ocean dining experience. With the beach at your doorstep, thoughtful amenities, and exceptional service throughout your stay, The Sunny makes every getaway feel effortlessly relaxing and truly special.
The Sunny Hotel
16701 Collins Avenue, Sunny Isles Beach, Florida 33160
Toll Free: 1-800-327-5476
Email: info@thesunnyhotel.com
Hotel website: https://www.thesunnyhotel.comWe've reserved a block of rooms for conference participants at a discounted rate. Use the booking link below to book at the discounted rate.
Rates start at just $349 and go up to $509. Please note the discounted room rate expires on February 1, 2027.
You can also call 800-327-5476 or email Alexandra Kretzschmar at akretzschmar@thesunnyhotel.com and mention the "University of Miami Miller School of Medicine Psychiatry Course" for the discounted hotel rate.
Inquiries
Please email Tonia Attard at psychcme@med.miami.edu or call 941-539-0500.
10 a.m.- 4 p.m. (EST) Monday–Friday.
Things to Do in Miami
- Everglades
- Miami Double Decker City Tour
- Miami Zoo
- Miami Aquarium
- Miami Heat Game
- Miami Dolphins Game
- Miami Boat Show
- South Beach Food and Wine Festival
Golf Courses
- PGA National Resort
- Trump National Doral Miami
- Normandy Shores Golf Club
- Miami Shores Country Club
- JW Marriott Miami Turnberry Resort – Soffer Course
- Miami Beach Golf Course
Tennis Courts
- Flamingo Park
- Margaret Pace Park
- Crandon Park Tennis Center
- Fisher Island Club
- Morningside Tennis Center
Restaurants
- Nobu Miami
- Cecconi’s Miami
- Ocean Social by Chef Tristan Epps
- Prime 54
- Donna Mare Trattoria
- Santorini – Best Happy Hour in Town
Misc Fun Things to Do